Prothena reported -37944000 in EBIT for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -113016000 68.36M
Agios Pharmaceuticals AGIO:US $ -101145000 3.68M
Akebia Therapeutics AKBA:US $ -58493000 7.66M
ALKERMES ALKS:US -26585000 28.97M
Alnylam Pharmaceuticals ALNY:US $ -146732000 47.83M
Amgen AMGN:US $ 2500M 196M
Biogen BIIB:US $ 531.5M 11.7M
Biomarin Pharmaceutical BMRN:US $ 29.33M 95.21M
Bluebird Bio BLUE:US $ -120346000 138.95M
Exelixis EXEL:US $ 83.24M 33.4M
Intercept Pharmaceuticals ICPT:US $ -10272000 10.59M
Intra Cellular Therapies ITCI:US $ -72662000 13.34M
IONIS PHARMACEUT IONS:US $ -57504000 278.11M
Macrogenics MGNX:US $ -66638000 8.4M
Nektar Therapeutics NKTR:US $ -115085000 2.17M
Neurocrine Biosciences NBIX:US $ 3.1M 60.9M
Prothena PRTA:US -37944000 4.85M
Regeneron Pharmaceuticals REGN:US $ 1286.6M 1353.1M
Seattle Genetics SGEN:US $ -133050000 39.02M
Ultragenyx Pharmaceutical RARE:US $ -136632000 34.07M
Vertex Pharmaceuticals VRTX:US $ 1033.4M 157.68M
Vital Therapies VTL:US $ -21435000 286K
Xoma XOMA:US $ -2065000 32.43M
YTE INCY:US $ 127.66M 7.71M